Search


A deep dive into the oncology target PRMT5 with the CEO of Tango Therapeutics
Barbara Weber walks us through the science of PRMT5, shares her reaction to recent data, and describes how programs are designed differently
Oct 20, 2023
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.